442. Deputy Steven Matthews asked the Minister for Health the steps that are being taken for polycythemia vera patients who rely on Pegasys (peginterferon alfa-2a) to manage this condition and who are now affected by a Pegasys shortage that was announced by the Health Products Regulatory Authority on 1 August 2024. [45620/24]

As this query relates to the clinical management of patients, the Deputy's question has been referred to the Health Service Executive for their attention and direct response.